The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2016 | ESMO 2016: From disease treatment to patient care
Solange Peters, MD, PhD of Lausanne University Hospital, Lausanne, Switzerland kicks-off the first press conference at ESMO 2016. This year’s congresses focuses not only on disease treatment, but also on patient care, as demonstrated by the variety of talks on supportive care and patient-focused sessions. Solange Peters, the current ESMO Press Officer provides an overview of the themes covered this year in this short clip.
Recorded at the 2016 annual meeting of the European Society of Medical Oncology (ESMO), held in Copenhagen, Denmark.
